Please login to the form below
The Lancet
This page shows the latest The Lancet news and features for those working in and with pharma, biotech and healthcare.
AI model shows promise in detecting lung cancer earlier
Lung cancer accounts for more than 20% of cancer deaths in the UK. ... The results, which have been published in the Lancet’s eBioMedicine, indicate that the model was able to identify each lung nodule’s risk of cancer with an AUC of
Latest news
-
Positive results for Astellas’ zolbetuximab in gastric cancer published in The Lancet
clinical benefit following CLDN18.2-targeted therapy in any tumour type, and we are honoured that it has been published in The Lancet.”. ... The Lancet’s decision to publish the SPOTLIGHT study reinforces the value this data provides to the
-
Study unveils ‘breakthrough biomarker’ for Parkinson’s disease
In a paper published in the journal Lancet Neurology, the team detailed how the α-synuclein seeding amplification assay can confirm the presence of the alpha-synuclein protein – known as the ... It has previously been possible to confirm the presence
-
Positive results for Sanofi’s haemophilia therapy published in The Lancet
Sanofi’s investigational haemophilia therapy has shown significant improvements in bleed protection across all types of the disorder, according to two phase 3 studies recently published in The Lancet and The ... In ATLAS-INH, published in The Lancet, 66
-
Results for Astellas’ non-hormonal menopause drug published in The Lancet
Symptoms such as hot flashes and night sweats are the most common symptoms of menopause. ... published in The Lancet.
-
Novartis’ Cosentyx shows continued improvement in hidradenitis suppurativa patients
An estimated one in 100 people globally are affected by the inflammatory skin disease. ... Novartis’ Cosentyx (secukinumab) has demonstrated sustained efficacy and symptom improvement in patients with the inflammatory skin disease hidradenitis
More from news
Approximately 8 fully matching, plus 160 partially matching documents found.
Latest Intelligence
-
Working together to achieve better patient pathways
Critchley highlighted studies in publications The Lancet and Social Science &Medicine stating that empathetic care can improve the quality and speed of a patient’s recovery. ... Danny Buckland is a journalist specialising in the healthcare industry.
-
Pharma’s vital role in sustainability and corporate social responsibility
An ambitious response runs through all layers of the industry, with global companies prominent at COP27 outlining decarbonisation plans across active pharmaceutical ingredient supply chains, but the Lancet Countdown 2022 Report ... framed both the
-
Creating the urgency and drive needed to tackle antimicrobial resistance
In January 2022 when Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis was published in The Lancet, there was a positive response from HCPs to use this to ... Also sharing The Lancet article, Rita Issa referred to her
-
Behaviour change – a maze of decisions influenced by personal habits, experiences and intentions
The ultimate lesson is that we must see people as people, not patients. ... The desire to change behaviours is omni- present.”. The impact of COVID-19 on cancer screening created a fertile ground for human behaviour research, with The Lancet reporting
-
Alzheimer’s: the search for a cure
In closing, a 2020 report by the Lancet Commission identified 12 lifestyle-related risk factors for dementia. ... By seeking help and making simple lifestyle changes, we can delay the onset of dementia by 40%, according to the Lancet Commission report.
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Sudler London makes three senior hires
Boulding joins with more than 25 years of experience in the pharma industry, having worked in sales and marketing prior to moving into senior client roles in healthcare advertising agencies. ... Pound, too, has significant medical communications and
-
ROCK names new managing director
His experience prior to Pollen includes the role of managing director for Cohn &Wolfe's healthcare business and senior business director at Ogilvy Healthworld. ... He also has experience at publishing firms The Lancet and Medpress.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Latest from PMHub
-
The power of influence in transforming women’s health
In 2003, prescriptions for HRT in England were 20.7% below the 2001 figure. ... Lancet. August, 2003. DOI:https://doi.org/10.1016/S0140-6736(03) 14065-2.
-
Addressing Climate Impact: The Healthcare Paradox
Observable effects of climate change are already being felt – for example, the Lancet’s 2019 report on the infection rates of dengue fever (expressed as vectorial capacity for transmissions) showed that ... In 2015 the global pharmaceutical industry
-
Fake News is Bad for your Health
Trust in vaccines fell as a result of emotional contagion, triggered by the 1998 publication of Andrew Wakefield's paper in the Lancet linking the MMR vaccine with autism and bowel ... But the majority of the public don't even read the mainstream media.
-
World Diabetes Day: Interaction and impact of diabetes on mental health
Including a case study showing the perspective of a young person newly diagnosed with type 1 diabetes. ... The Lancet Diabetes &Endocrinology, 3(6), pp.450-460. 17. Zhang, X., Norris, S.L., Gregg, E.W., Cheng, Y.J., Beckles, G.
-
Exploring MINT: Part 4 - Turkey
Notably in 2013, an article was published in the Lancet hailing the success of the nation’s healthcare reforms as part of the government’s decade-long ‘Health Transformation Program’, which ... Turkey’s potential entry to the EU has been under
More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.
Subscribe to our email news alerts
- COVID-19 could be key in identifying viruses with pandemic potential
- Novo Nordisk Foundation commits €127m for new cell therapy facility
- Alzheimer’s Research UK launches ‘Change The Ending’ campaign
- AstraZeneca and Daiichi Sankyo share positive results from phase 3 breast cancer study
- ICR and Merck renew strategic alliance for development of new cancer drugs
- DeepMind’s AI tool classifies effects of mutations in genetic diseases
No results were found
PMHub
Oxford PharmaGenesis
Oxford PharmaGenesis is an independently owned HealthScience communications consultancy, providing services to the healthcare industry, professional societies and patient groups....
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
